Clinical Trial Update: A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring

View source ↗

Summary

This clinical trial update describes safety findings for deucravacitinib exposure in pregnant women and their offspring as part of a psoriasis study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Sotyktu (Deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Psoriasis | Status: ACTIVE_NOT_RECRUITING